Home Stock Market Walgreens, Baidu, Novavax and others

Walgreens, Baidu, Novavax and others

Walgreens, Baidu, Novavax and others


Try the businesses making headlines earlier than the bell:

Walgreens (WBA) – The drug retailer operator reported an adjusted quarterly revenue of $1.59 per share, 19 cents above estimates, with income additionally topping Wall Avenue forecasts. Comparable pharmacy gross sales rose 7.3%, helped by demand for Covid vaccines. Walgreens shares initially rose within the premarket however misplaced their good points and dipped unfavorable.

Baidu (BIDU) – Baidu misplaced 2.2% in premarket buying and selling after the SEC added the search engine firm to its listing of U.S.-traded China shares that might be delisted if they do not enable American regulators to evaluate three years’ price of economic audits. On-line leisure firm iQYI (IQ) was additionally added to that listing, with its shares sliding 6.6%.

Novavax (NVAX) – The drug maker’s shares gained 1.3% in premarket buying and selling after it requested EU regulators to clear its Covid-19 vaccine to be used in youngsters.

Superior Micro Gadgets (AMD) – Superior Micro Gadgets was downgraded to “equal weight” from “obese” at Barclays, which factors to cyclical threat in a number of totally different finish markets for the semiconductor maker. AMD fell 2.2% in premarket motion.

HP Inc. (HPQ), Dell Applied sciences (DELL) – Morgan Stanley downgraded each pc gear makers, predicting corporations will shift spending away from {hardware} because of macroeconomic uncertainty. HP was reduce to “underweight” from “equal-weight” whereas Dell was reduce to “equal-weight” from “obese.” HP fell 4.5% in premarket buying and selling, whereas Dell misplaced 2.6%.

Kinross Gold (KGC) – The gold mining firm is in talks to promote a Russian mine to Russia-backed funding agency Fortiana Holdings, in response to individuals accustomed to the matter who spoke to The Wall Avenue Journal. It might be the primary sale of an asset left behind in Russia by a Western firm.

Amylyx Prescribed drugs (AMLX) – An FDA panel voted towards recommending the approval of an experimental ALS drug developed by Amylyx. The panel mentioned research information did not show that the drug was efficient in combating the illness. Amylyx erased early premarket losses to rise by 2.5%.

Robinhood Markets (HOOD) – Robinhood received a positive ruling in a Massachusetts case, with a decide deciding the state overstepped its authority in adopting a brand new fiduciary normal for brokerages working within the state. The brokerage agency had been accused by regulators of encouraging its clients to take undue dangers.

Expensify (EXFY) – Expensify tumbled 14.3% within the premarket after the web expense administration firm reported a lower-than-expected quarterly revenue and issued a weaker-than-expected income forecast for the present quarter.


Source link


Please enter your comment!
Please enter your name here